Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q3 2016 · 10-Q
Revenue$2.48B$2.48B−11.1% vs Q3 2015 Net Income-$1.22B-$1.22BN/M vs Q3 2015 EPS Diluted-$3.49-$3.49N/M vs Q3 2015 Operating Income-$863,000,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
Free Cash Flowderived$517,000,000−24.2% Margins · derivedOperating margin-34.8%−50.9 pt vs Q3 2015
Net margin-49.2%−51.0 pt vs Q3 2015
ended Sep 30, 2016 · filed Nov 9, 2016 · 40 d after period end